Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2025

Radiation for high-risk asymptomatic bone metastases – an implementation science perspective

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Randomized controlled trial demonstrates lower skeletal-related events in asymptomatic bone metastases, indicating the need for implementation research.

Key Points

  • Skeletal-related events occurred in only 1.6% of bone metastases receiving radiation compared to 29% with standard care.
  • Among evaluable patients, 13.8% experienced complications in standard care, while none did in the radiation arm.
  • This randomized controlled trial evaluated the efficacy of radiation therapy among 78 patients with metastatic tumors.
  • The findings may enable earlier implementation of radiation therapy for better patient outcomes in future research.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/68af73567567bf4f94fec97dhttps://doi.org/10.52843/cassyni.5631s2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oncological outcomes and safety after spinal reirradiation with stereotactic body radiotherapy.2025
  2. 2Efficacy and Safety of Simultaneous Integrated Boost Followed by Selective Sequential Boost Radiotherapy for Spinal Metastases: A Single-Arm Retrospective Study2025
  3. 3Radiation therapy to metastatic sites among patients with high-risk neuroblastoma in first-line therapy2025
  4. 4Neoadjuvant stereotactic radiotherapy for brain metastasis: a review of ongoing clinical trials2025
  5. 5PROTOCOL FOR A PROSPECTIVE, SINGLE-ARM, PHASE II CLINICAL TRIAL EVALUATING THE EffiCACY AND SAFETY OF NEO-ADJUVANT STEREOTACTIC RADIOSURGERY PRIOR TO SURGICAL RESECTION OF A DOMINANT BRAIN METASTASIS2025